pubmed-article:18064332 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18064332 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:18064332 | lifeskim:mentions | umls-concept:C0040053 | lld:lifeskim |
pubmed-article:18064332 | lifeskim:mentions | umls-concept:C0038257 | lld:lifeskim |
pubmed-article:18064332 | lifeskim:mentions | umls-concept:C0255567 | lld:lifeskim |
pubmed-article:18064332 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
pubmed-article:18064332 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
pubmed-article:18064332 | lifeskim:mentions | umls-concept:C1514983 | lld:lifeskim |
pubmed-article:18064332 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:18064332 | pubmed:dateCreated | 2007-12-7 | lld:pubmed |
pubmed-article:18064332 | pubmed:abstractText | Low-response to the P2Y12 adenosine diphosphate (ADP)-receptor antagonist clopidogrel was suggested to correspond to a higher incidence of stent thrombosis (ST). This prospective observational study assessed the capability of two platelet function assays, e.g. direct measurement of the phosphorylation status of vasodilator-stimulated phosphoprotein (VASP) and ADP-induced platelet aggregation for definition of the individual risk to develop ST. Ninety-nine patients with an elevated high risk to develop ST were enrolled. All patients received a dual antiplatelet therapy consisting of 100 mg aspirin and 75 mg clopidogrel during an observation period of six months. Flow cytometry of VASP phosphorylation and densitometrically-determined measurement of ADP-induced platelet aggregation was performed 72-96 hours after stent implantation. These data were related to angiographically confirmed ST. Nine patients suffered from angiographically confirmed ST (9.1%). The meanVASP-platelet reactivity indices (VASP-PRI) and values for ADP-induced platelet aggregation in the ST group were significantly higher (60.8 +/- 13.0 and 60.9 +/- 13.1, respectively) compared to patients without ST (41.3 +/- 14.0 and 50.8 +/- 14.4, P < 0.001 vs. 0.048, respectively). There was a fair correlation between both methods using non-linear regression analysis (r = 0.332). In a multivariate analysis, VASP was the only independent predictor of ST and was superior to previously identified angiographic parameters. Receiver- operator characteristic (ROC) curve analysis revealed a cut-off value for VASP-PRI of <48% to be associated with low risk of ST. In conclusion, determination of VASP phosphorylation is superior to conventional platelet aggregometry and angiographic parameters for assessing the risk of ST. Patients with a VASP-PRI >48% seem to have a significantly increased risk. | lld:pubmed |
pubmed-article:18064332 | pubmed:language | eng | lld:pubmed |
pubmed-article:18064332 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18064332 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18064332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18064332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18064332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18064332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18064332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18064332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18064332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18064332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18064332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18064332 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18064332 | pubmed:month | Dec | lld:pubmed |
pubmed-article:18064332 | pubmed:issn | 0340-6245 | lld:pubmed |
pubmed-article:18064332 | pubmed:author | pubmed-author:KelmMalteM | lld:pubmed |
pubmed-article:18064332 | pubmed:author | pubmed-author:WeberChristia... | lld:pubmed |
pubmed-article:18064332 | pubmed:author | pubmed-author:HoffmannRaine... | lld:pubmed |
pubmed-article:18064332 | pubmed:author | pubmed-author:KieferPaulP | lld:pubmed |
pubmed-article:18064332 | pubmed:author | pubmed-author:BlindtRüdiger... | lld:pubmed |
pubmed-article:18064332 | pubmed:author | pubmed-author:MüllerRobertR | lld:pubmed |
pubmed-article:18064332 | pubmed:author | pubmed-author:YagmurErayE | lld:pubmed |
pubmed-article:18064332 | pubmed:author | pubmed-author:StellbrinkKat... | lld:pubmed |
pubmed-article:18064332 | pubmed:author | pubmed-author:de... | lld:pubmed |
pubmed-article:18064332 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18064332 | pubmed:volume | 98 | lld:pubmed |
pubmed-article:18064332 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18064332 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18064332 | pubmed:pagination | 1329-34 | lld:pubmed |
pubmed-article:18064332 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:meshHeading | pubmed-meshheading:18064332... | lld:pubmed |
pubmed-article:18064332 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:18064332 | pubmed:articleTitle | The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis. | lld:pubmed |
pubmed-article:18064332 | pubmed:affiliation | Department of Cardiology, University Hospital Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. ruediger.blindt@post.rwth-aachen.de | lld:pubmed |
pubmed-article:18064332 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18064332 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:18064332 | pubmed:publicationType | Comparative Study | lld:pubmed |
entrez-gene:7408 | entrezgene:pubmed | pubmed-article:18064332 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18064332 | lld:entrezgene |
lhgdn:association:27380 | lhgdn:found_in | pubmed-article:18064332 | lld:lhgdn |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18064332 | lld:pubmed |